Observation on the effect of dual-site transcranial magnetic stimulation on anxiety disorders

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049236

Enrollment

Unknown

Registered

2021-07-28

Start date

2019-11-01

Completion date

Unknown

Last updated

2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorder

Interventions

group 1:frontal-parietal double-site stimulation (1500 pulses)

group 2:frontal-parietal double-site stimulation (750 pulses)

group 3:frontal single-site stimulation

group 4:parietal single-site stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18-65 years; in line with diagnostic criteria of generalized anxiety disorder in DSM-5; Hamilton Anxiety Scale>14 points; no antidepressants or benzodiazepines taken in the last 1 week.

Exclusion criteria

Exclusion criteria: Other types of anxiety disorders; bipolar disorder, schizophrenia and other mental diseases; neurological diseases; a history of head trauma or surgery; EEG and MRI examinations; pregnancy and lactation.

Design outcomes

Primary

Measure	Time frame
Hamilton Anxiety Scale;	—

Countries

China

Contacts

Public ContactWang Yuping

Xuanwu Hospital

wangyuping01@sina.cn+86 13501186298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026